167 related articles for article (PubMed ID: 8050207)
1. Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome.
Prata MM; Nogueira AC; Pinto JR; Correia AM; Vicente O; Rodrigues MC; Miguel MJ
Clin Nephrol; 1994 May; 41(5):277-83. PubMed ID: 8050207
[TBL] [Abstract][Full Text] [Related]
2. [Comparison between lovastatin and gemfibrozil in treatment of primary hyperlipidemias].
Bertolami MC; Martinez TL; Faludi AA; Pinto LE; Melo RS; Bismarck ZF; Batlouni M
Arq Bras Cardiol; 1991 May; 56(5):407-12. PubMed ID: 1823741
[TBL] [Abstract][Full Text] [Related]
3. Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome.
Wanner C; Böhler J; Eckardt HG; Wieland H; Schollmeyer P
Clin Nephrol; 1994 Mar; 41(3):138-43. PubMed ID: 8187355
[TBL] [Abstract][Full Text] [Related]
4. Lovastatin in the treatment of hypercholesterolemia in nephrotic syndrome due to diabetic nephropathy stage IV-V.
Biesenbach G; Zazgornik J
Clin Nephrol; 1992 Jun; 37(6):274-9. PubMed ID: 1638777
[TBL] [Abstract][Full Text] [Related]
5. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
[TBL] [Abstract][Full Text] [Related]
6. The effects of lovastatin in hyperlipidemic patients with the nephrotic syndrome.
Kasiske BL; Velosa JA; Halstenson CE; La Belle P; Langendörfer A; Keane WF
Am J Kidney Dis; 1990 Jan; 15(1):8-15. PubMed ID: 2294737
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin versus bezafibrate for hyperlipemia treatment after heart transplantation.
Hidalgo L; Zambrana JL; Blanco-Molina A; López-Granados A; Concha M; Casares J; Jiménez-Pérez J; López-Miranda J; Pérez-Jiménez F
J Heart Lung Transplant; 1995; 14(3):461-7. PubMed ID: 7654731
[TBL] [Abstract][Full Text] [Related]
8. Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism.
Vega GL; Grundy SM
Kidney Int; 1988 Jun; 33(6):1160-8. PubMed ID: 3165483
[TBL] [Abstract][Full Text] [Related]
9. Relative effectiveness of niacin and lovastatin for treatment of dyslipidemias in a health maintenance organization.
O'Connor PJ; Rush WA; Trence DL
J Fam Pract; 1997 May; 44(5):462-7. PubMed ID: 9152263
[TBL] [Abstract][Full Text] [Related]
10. Plasma lipids and lipoprotein-cholesterol distribution in nephrotic syndrome patients during short term high dose steroid treatment.
Arije A; Erasmus RT; Anjorin SA
Cent Afr J Med; 1993 Oct; 39(10):211-5. PubMed ID: 8020077
[TBL] [Abstract][Full Text] [Related]
11. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
[TBL] [Abstract][Full Text] [Related]
12. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
13. Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).
Cui Y; Watson DJ; Girman CJ; Shapiro DR; Gotto AM; Hiserote P; Clearfield MB
Am J Cardiol; 2009 Sep; 104(6):829-34. PubMed ID: 19733719
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT
Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066
[TBL] [Abstract][Full Text] [Related]
15. Impact on lipoprotein profile after long-term testosterone replacement in hypogonadal men.
Berg G; Schreier L; Geloso G; Otero P; Nagelberg A; Levalle O
Horm Metab Res; 2002 Feb; 34(2):87-92. PubMed ID: 11972293
[TBL] [Abstract][Full Text] [Related]
16. [Lovastatin efficacy and tolerance in primary hypercholesterolemia. The German Lovastatin Study Group].
Thiery J; Basten A; Sommerburg C; Seidel D
Dtsch Med Wochenschr; 1991 Jun; 116(23):887-94. PubMed ID: 2040207
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol metabolism in glomerular cells: effect of lipoproteins from nephrotic patients.
Wanner C; Krämer-Guth A; Nauck M; Quaschning T; Pavenstädt H; Schollmeyer P
Miner Electrolyte Metab; 1996; 22(1-3):39-46. PubMed ID: 8676822
[TBL] [Abstract][Full Text] [Related]
18. Postmarketing analysis of lovastatin use in the VA Northern California System of Clinics: a retrospective, computer-based study.
Swislocki AL; Lin K; Cogburn D; Fann KY; Khuu DT; Noth RH
Am J Manag Care; 1997 Oct; 3(10):1537-45. PubMed ID: 10178460
[TBL] [Abstract][Full Text] [Related]
19. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
März W; Grützmacher P; Paul D; Siekmeier R; Schoeppe W; Gross W
Int J Clin Pharmacol Ther; 1994 Feb; 32(2):92-7. PubMed ID: 8004365
[TBL] [Abstract][Full Text] [Related]
20. Impact of fluvastatin on hyperlipidemia after renal transplantation.
Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]